Norpace
Product Images NDC 68151-0526

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norpace (NDC 68151-0526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 0526)

Norpace CR 100 mg extended-release capsules packaging label showing the active ingredient disopyramide phosphate, manufacturer Pfizer, lot number, expiration date 07/14, and product NDC 68151-0526. The label indicates prescription use only.*

FDA Label Image

Chemical Structure (Norpace 01)

Chemical structure diagram of the active ingredient in Norpace, showing the molecule labeled as α-[2-(diisopropylamino)ethyl]-α-phenyl-2-pyridineacetamide phosphate.*

FDA Label Image

G.d. Searle Llc Logo (Norpace 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.